Free Trial
→ 5 Stocks that could triple in a week (From Traders Agency) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 4 of 15

Slide 4
Back to 3
Continue to 5
 
Back to 3
Continue to 5
 

Corcept Therapeutics (NASDAQ:CORT)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$65.25 (25.9% Upside)

About Corcept Therapeutics

Corcept Therapeutics logoCorcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/31/2024HC WainwrightReiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
10/18/2024Sandler O'NeillReiterated RatingBuy ➝ Buy
10/18/2024HC WainwrightBoost Price TargetBuy ➝ Buy$45.00 ➝ $80.00
9/30/2024Truist FinancialBoost Price TargetBuy ➝ Buy$65.00 ➝ $76.00
9/18/2024Piper SandlerBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $67.00
7/30/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$38.00 ➝ $38.00
7/30/2024HC WainwrightBoost Price TargetBuy ➝ Buy$40.00 ➝ $45.00
7/30/2024Piper SandlerBoost Price TargetOverweight ➝ Overweight$35.00 ➝ $38.00
7/1/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$35.00 ➝ $35.00
6/17/2024Truist FinancialReiterated RatingBuy ➝ Buy$65.00 ➝ $65.00
Slide 4
Back to 3
Continue to 5
 

Watch this before it gets removed (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

More From MarketBeat
Central Bank Abandons USD
Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...
True Gold Republic | Sponsored
7 Defense Stocks That Don’t Need the Election to Move Higher
The defense sector is a good place for investors who are looking for both growth and value. While it's not one...
MarketBeat
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?
Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...
Golden Crest | Sponsored
15 Healthcare Stocks that Analysts Love in a Post-Pandemic World
There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...
MarketBeat
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...
Colonial Metals | Sponsored
7 Stocks That Can Help You Cash In on the GLP-1 Revolution
You know that an idea has become mainstream when you hear people discuss it in casual conversation. That's som...
MarketBeat